National Institute on Drug Dependence, Peking University, Beijing 100191, China.
Department of Pharmacy, China-Japan Friendship Hospital, Beijing 100029, China.
Int J Neuropsychopharmacol. 2014 Mar;17(3):469-84. doi: 10.1017/S1461145713001429. Epub 2013 Nov 26.
Drug addiction is a major public health issue, yet the underlying adaptation of neural networks by drugs of abuse is not fully understood. We have previously linked chaperone heat shock protein 70 (Hsp70) to drug-induced adaptations. Focusing on the NAc core and shell, the present study aims to provide further findings for our understanding of the relation between behavioural sensitization to morphine and Hsp70 at transcriptional and functional levels in rats. Firstly, we delineated the characteristics of behavioural sensitization induced by a single morphine exposure (1-10 mg/kg, s.c.). Secondly, Hsp70 protein expression in the NAc core was time- and dose-relatedly induced during the development of behavioural sensitization to a single morphine exposure in rats, and Pearson analysis indicated a positive correlation between behavioural sensitization and Hsp70 expression in NAc core. Thirdly, at the transcriptional level, intra-NAc core injection of the specific heat shock factor-I (HSF-I) inhibitor N-Formyl-3,4-methylenedioxy-benzylidine-γ-butyrolactam (KNK437) suppressed Hsp70 expression and the development of behavioural sensitization, while the HSF-I specific inducer geranylgeranylacetone (GGA) promoted both of them. Interestingly, intra-NAc shell injection of KNK437 or GGA did not affect the development of behavioural sensitization. Finally, both the functional inhibition of Hsp70 ATPase activity by methylene blue (MB), and the antagonism of Hsp70 substrate binding site (SBD) activity by pifithrin-μ (PES) impaired the development of behavioural sensitization when they were microinjected into the NAc core. Taken together, the critical involvement of chaperone Hsp70 in behavioural sensitization to morphine identifies a biological target for long-lasting adaptations with relevance to addiction.
药物成瘾是一个主要的公共卫生问题,但滥用药物引起的神经网络适应机制尚未完全了解。我们之前已经将伴侣蛋白热休克蛋白 70(Hsp70)与药物引起的适应联系起来。本研究聚焦于伏隔核核心和壳区,旨在进一步阐明吗啡诱导的行为敏化与 Hsp70 在转录和功能水平上的关系。首先,我们描述了单次吗啡暴露(1-10mg/kg,sc)诱导的行为敏化特征。其次,在大鼠单次吗啡暴露诱导的行为敏化过程中,Hsp70 蛋白在伏隔核核心中的表达呈现时间和剂量相关性,Pearson 分析表明行为敏化与伏隔核核心中的 Hsp70 表达呈正相关。第三,在转录水平上,内侧伏隔核核心内注射特异性热休克因子-I(HSF-I)抑制剂 N-Formyl-3,4-methylenedioxy-benzylidine-γ-butyrolactam(KNK437)可抑制 Hsp70 表达和行为敏化的发展,而 HSF-I 特异性诱导剂香叶基丙酮(GGA)则促进了这两者。有趣的是,内侧伏隔核壳区注射 KNK437 或 GGA 并不影响行为敏化的发展。最后,当 Hsp70 ATP 酶活性的功能抑制剂亚甲蓝(MB)或 Hsp70 底物结合位点(SBD)活性的拮抗剂 Pifithrin-μ(PES)微注射到伏隔核核心时,都会损害行为敏化的发展。总之,伴侣蛋白 Hsp70 在吗啡诱导的行为敏化中的关键作用确定了与成瘾相关的持久适应的生物学靶标。